HIGH RISK OF FLARES DURING PREGNANCY IN WOMEN WITH RHEUMATOID ARTHRITIS WHO DISCONTINUE TREATMENT WITH TNF-INHIBITORS AT CONCEPTION

被引：3
|
作者：
Fischer-Betz, R. [1 ]
Sander, O. [1 ]
Specker, C. [2 ]
Brinks, R. [3 ]
Schneider, M. [3 ]
机构：
[1] Heinrich Heine Univ, Rheumatol, Dusseldorf, Germany
[2] St Josef Hosp, Rheumatol, Essen, Germany
[3] Heinrich Heine Univ, Univ Hosp Dusseldorf, Hiller Res Unit Rheumatol, Dusseldorf, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4555
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0169
引用
收藏
页码：715 / 715
页数：1
相关论文
共 50 条
  • [1] High Risk of Flares during Pregnancy in Women with Rheumatoid Arthritis Who Discontinue Treatment with TNF Inhibitors at Conception
    Fischer-Betz, Rebecca
    Sander, Oliver
    Specker, Christof
    Brinks, Ralph
    Schneider, Matthias
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] USE OF TNF-INHIBITORS BEFORE, DURING AND THE FIRST YEAR AFTER PREGNANCY AMONG WOMEN WITH RHEUMATOID ARTHRITIS
    Bjorngaard, H.
    Koksvik, H.
    Jakobsen, B.
    Wallenius, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1446 - 1446
  • [3] Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis
    Tanaka, Yoshiya
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (03) : 319 - 326
  • [4] A cost-efficacy comparison of TNF-inhibitors in the treatment of rheumatoid arthritis
    Chiou, C
    Malone, DC
    Wanke, LA
    Yu, EB
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 269 - 269
  • [5] Pregnancy outcomes in patients with rheumatoid arthritis who discontinue methotrexate treatment to conceive
    Hiroko Nagafuchi
    Yutaka Goto
    Tomofumi Kiyokawa
    Seido Ooka
    Kimito Kawahata
    [J]. Clinical Rheumatology, 2022, 41 : 669 - 675
  • [6] Pregnancy outcomes in patients with rheumatoid arthritis who discontinue methotrexate treatment to conceive
    Nagafuchi, Hiroko
    Goto, Yutaka
    Kiyokawa, Tomofumi
    Ooka, Seido
    Kawahata, Kimito
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (03) : 669 - 675
  • [7] The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
    Ingrid Lekander
    Fredrik Borgström
    Jörgen Lysholm
    Ronald F. van Vollenhoven
    Staffan Lindblad
    Pierre Geborek
    Gisela Kobelt
    [J]. The European Journal of Health Economics, 2013, 14 : 863 - 873
  • [8] SEVERE EXTRA-ARTICULAR MANIFESTATIONS IN RHEUMATOID ARTHRITIS: RISK FACTORS AND INCIDENCE IN RELATION TO TREATMENT WITH TNF-INHIBITORS
    Theander, L.
    Wahlin, B. -M. Nyhall
    Nilsson, J. -A.
    Jacobsson, L.
    Geborek, P.
    Petersson, I. F.
    Turesson, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 424 - 424
  • [9] Treatment of rheumatoid Arthritis in Practice - a Comparison of Tocilizumab vs. TNF-Inhibitors (CONSENS)
    Backhaus, M.
    Kaufmann, J.
    Richter, C.
    Vollmer, M.
    Volberg, C.
    Wassenberg, S.
    Roske, A.
    Hellmann, P.
    Gaubitz, M.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 119 - 120
  • [10] The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
    Lekander, Ingrid
    Borgstrom, Fredrik
    Lysholm, Jorgen
    van Vollenhoven, Ronald F.
    Lindblad, Staffan
    Geborek, Pierre
    Kobelt, Gisela
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2013, 14 (06): : 863 - 873
12345